{"lastClose": 4.650000095367432, "len": 1131, "date": "2023-04-11", "alpha_1": -0.46769947478885476, "beta_1": 1.5314183878964769, "drawup_1": 1.5486725887776869, "natr_1": 17.318025941556417, "sup_1": -0.0021506209940764616, "res_1": 0.6924730931393527, "bullPattern_1": [], "bearPattern_1": ["3OUTSIDE"], "rsi_1": 26.666668593281333, "adx_1": 13.764204550446873, "drawdown_1": -0.7378472204975508, "stratHoldSharpe_1": -0.48947045563341224, "stratHoldAlpha_1": 250.6698635293068, "stratHoldDrawdown_1": -0.6981625691804061, "alpha_3mo": -0.8921019826843294, "beta_3mo": 1.5499259439996718, "drawup_3mo": 0.2888540322832984, "natr_3mo": 17.318025941556417, "sup_3mo": -0.03369177472326269, "res_3mo": 0.1476702095837704, "bullPattern_3mo": ["SHORTLINE"], "bearPattern_3mo": [], "rsi_3mo": 30.601101154570724, "adx_3mo": 44.086011948777646, "drawdown_3mo": -0.4482338381534542, "stratHoldSharpe_3mo": -2.752325783274419, "stratHoldAlpha_3mo": 249.567945392602, "stratHoldDrawdown_3mo": -0.4091414248053281, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Name": "Allogene Therapeutics Inc.", "Sector": "Health Care", "Market Cap": 671912831, "IPO Year": 2018.0, "Country": "United States", "alpha%_1": 0.076018408463934, "beta%_1": 0.8733844512823883, "drawup%_1": 0.9969221340295986, "natr%_1": 0.9999999707402315, "drawdown%_1": 0.026803520253648072, "stratHoldSharpe%_1": 0.24340095261584715, "stratHoldAlpha%_1": 0.09938359058051327, "stratHoldDrawdown%_1": 0.018164473572276192, "alpha%_3mo": 0.09085585099386262, "beta%_3mo": 0.8025487617876063, "drawup%_3mo": 0.8693649650979753, "natr%_3mo": 0.9999999514451391, "drawdown%_3mo": 0.016861103604046013, "stratHoldSharpe%_3mo": 0.06902504467521237, "stratHoldAlpha%_3mo": 0.010507560688019377, "stratHoldDrawdown%_3mo": 0.016472670371025795}